C WorldWide Group Holding A S Has $28.44 Million Holdings in Elevance Health, Inc. $ELV

C WorldWide Group Holding A S trimmed its position in shares of Elevance Health, Inc. (NYSE:ELV) by 3.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 88,000 shares of the company’s stock after selling 3,054 shares during the quarter. Elevance Health makes up about 0.4% of C WorldWide Group Holding A S’s investment portfolio, making the stock its 27th biggest position. C WorldWide Group Holding A S’s holdings in Elevance Health were worth $28,435,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of ELV. Physician Wealth Advisors Inc. increased its holdings in Elevance Health by 331.6% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company’s stock valued at $26,000 after purchasing an additional 63 shares in the last quarter. Activest Wealth Management grew its holdings in shares of Elevance Health by 66.7% during the third quarter. Activest Wealth Management now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 34 shares during the last quarter. Vermillion & White Wealth Management Group LLC increased its stake in shares of Elevance Health by 94.9% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 76 shares of the company’s stock valued at $30,000 after buying an additional 37 shares in the last quarter. BOK Financial Private Wealth Inc. acquired a new stake in shares of Elevance Health in the second quarter valued at $32,000. Finally, Motco raised its holdings in shares of Elevance Health by 334.8% in the third quarter. Motco now owns 100 shares of the company’s stock valued at $32,000 after buying an additional 77 shares during the last quarter. Institutional investors own 89.24% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have commented on ELV shares. Wells Fargo & Company decreased their price objective on shares of Elevance Health from $424.00 to $391.00 and set an “overweight” rating on the stock in a report on Friday, January 30th. UBS Group set a $400.00 price target on shares of Elevance Health in a research note on Thursday, January 29th. Mizuho set a $413.00 price target on shares of Elevance Health in a report on Friday, January 9th. Wall Street Zen raised Elevance Health from a “hold” rating to a “buy” rating in a report on Saturday, January 31st. Finally, Leerink Partners increased their price objective on Elevance Health from $350.00 to $357.00 and gave the company a “market perform” rating in a research report on Thursday, January 29th. Twelve analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Elevance Health presently has an average rating of “Moderate Buy” and a consensus price target of $390.55.

Elevance Health Stock Performance

Shares of Elevance Health stock opened at $340.34 on Thursday. The firm has a fifty day moving average of $352.02 and a two-hundred day moving average of $329.67. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.56 and a current ratio of 1.54. The stock has a market capitalization of $75.64 billion, a price-to-earnings ratio of 13.55, a PEG ratio of 1.89 and a beta of 0.50. Elevance Health, Inc. has a 52 week low of $273.71 and a 52 week high of $458.75.

Elevance Health (NYSE:ELV) last announced its quarterly earnings data on Wednesday, January 28th. The company reported $3.33 EPS for the quarter, topping analysts’ consensus estimates of $3.10 by $0.23. The business had revenue of $49.31 billion during the quarter, compared to analysts’ expectations of $49.52 billion. Elevance Health had a return on equity of 15.59% and a net margin of 2.84%.The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.84 earnings per share. Elevance Health has set its FY 2026 guidance at 25.500- EPS. As a group, equities research analysts predict that Elevance Health, Inc. will post 33.96 EPS for the current year.

Elevance Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 25th. Stockholders of record on Tuesday, March 10th will be paid a $1.72 dividend. This is a boost from Elevance Health’s previous quarterly dividend of $1.71. The ex-dividend date of this dividend is Tuesday, March 10th. This represents a $6.88 dividend on an annualized basis and a dividend yield of 2.0%. Elevance Health’s dividend payout ratio (DPR) is currently 27.23%.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.